Profound Medical Corp.PROFNASDAQ
Loading
| Metric | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 |
|---|---|---|---|---|---|
| Revenue Growth | +100.11% | +82.14% | -0.96% | +36.57% | +13.31% |
| Gross Profit Growth | +176.92% | +113.97% | +13.89% | +59.17% | +11.18% |
| EBITDA Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Income Growth | +0.00% | +0.00% | +0.00% | -172.52% | +0.00% |
| Net Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Diluted Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Weighted Average Shares Growth | +20.59% | +26.00% | +22.96% | +22.17% | +19.23% |
| Weighted Average Shares Diluted Growth | +20.59% | +26.00% | +22.96% | +22.17% | +19.23% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Free Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Receivables Growth | -21.27% | -23.69% | -46.95% | +16.16% | +39.98% |
| Inventory Growth | -37.36% | -28.09% | -9.31% | +29.56% | +94.50% |
| Asset Growth | +20.59% | -21.23% | -27.44% | +0.17% | +174.71% |
| Book Value per Share Growth | +21.11% | -34.62% | -40.53% | -15.30% | +26.30% |
| Debt Growth | -50.87% | -49.68% | -47.12% | -95.55% | +26.02% |
| R&D Expense Growth | +26.65% | +21.88% | +45.05% | -4.62% | -99.94% |
| SG&A Expenses Growth | +40.76% | +71.13% | +84.42% | -17.30% | -99.97% |